Compliance Alert: China imposes ‘two invoice’ limit on pharma distribution
China announced a new policy this month that aims to reduce corruption and control the price of pharmaceuticals by effectively requiring there to be at most one distributor between the pharmaceutical manufacturer and the end hospital.… Continue Reading